Stock listing
MDGL Stock Price, News, Filings & Events — Madrigal Pharmaceuticals, Inc.
Selected listing: MDGL · NASDAQ · USD · US
This page tracks Madrigal Pharmaceuticals, Inc.'s MDGL:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following MDGL:NASDAQ. MDGL:NASDAQ is the stock-level entry point for investors researching Madrigal Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Madrigal Pharmaceuticals, Inc. is a public company traded under the ticker MDGL in the American market. The company has a market capitalization of approximately $12.76 billion. Madrigal focuses on developing innovative therapies for liver and metabolic diseases.
- Ticker
- MDGL:NASDAQ
- Asset type
- Stock
- Market cap
- $12.33B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
Madrigal Pharmaceuticals, Inc. MDGL:NASDAQ stock context
This page tracks Madrigal Pharmaceuticals, Inc.'s MDGL:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following MDGL:NASDAQ. MDGL:NASDAQ is the stock-level entry point for investors researching Madrigal Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Madrigal Pharmaceuticals, Inc. is a public company traded under the ticker MDGL in the American market. The company has a market capitalization of approximately $12.76 billion. Madrigal focuses on developing innovative therapies for liver and metabolic diseases.
Latest news from Madrigal Pharmaceuticals, Inc.
Madrigal Appoints John C. Reed, M.D., Ph.D., to its Board of Directors
August 12, 2026
Madrigal Pharmaceuticals Reports Second-Quarter 2026 Financial Results and Provides Corporate Updates
July 30, 2026
Madrigal Pharmaceuticals to Release Second-Quarter 2026 Financial Results and Host Webcast on July 30, 2026
July 16, 2026
Madrigal Pharmaceuticals Announces Three New Resmetirom Patents, Strengthening IP Portfolio
July 13, 2026
Madrigal Pharmaceuticals to Participate in the 47th Annual Global Goldman Sachs Health Care Conference 2026
June 3, 2026
Madrigal Pharmaceuticals, Inc. earnings calls
Madrigal Pharmaceuticals, Inc. (MDGL) Q2 2026 Earnings Call
July 30, 2026 · Replay with transcript and chapters
Madrigal Pharmaceuticals, Inc. (MDGL) Q1 2026 Earnings Call
May 6, 2026 · Replay with transcript and chapters
Madrigal Pharmaceuticals, Inc. (MDGL) Q4 2025 Earnings Call
February 19, 2026 · Replay with transcript and chapters
Madrigal Pharmaceuticals, Inc. (MDGL) Q3 2025 Earnings Call
November 4, 2025 · Replay with transcript and chapters
Madrigal Pharmaceuticals, Inc. (MDGL) Q2 2025 Earnings Call
August 5, 2025 · Replay with transcript and chapters
Madrigal Pharmaceuticals, Inc. (MDGL) Q1 2025 Earnings Call
May 1, 2025 · Replay with transcript and chapters
Research Madrigal Pharmaceuticals, Inc.
Madrigal Pharmaceuticals, Inc. investor report
Review AI stock analysis and investor report context for MDGL:NASDAQ.
Madrigal Pharmaceuticals, Inc. company profile
View the public company page for Madrigal Pharmaceuticals, Inc. on 6ix.
Madrigal Pharmaceuticals, Inc. news
Read company news and market updates connected to Madrigal Pharmaceuticals, Inc..
Madrigal Pharmaceuticals, Inc. investor events
Find investor webinars, events, and replay context for Madrigal Pharmaceuticals, Inc..
Alternate listings
A2APCZ:LSX
DE · EUR
Alternate listing for Madrigal Pharmaceuticals, Inc.; the primary context on this page is MDGL:NASDAQ.
YDO1:GETTEX
DE · EUR
Alternate listing for Madrigal Pharmaceuticals, Inc.; the primary context on this page is MDGL:NASDAQ.
YDO1:TRADEGATE
DE · EUR
Alternate listing for Madrigal Pharmaceuticals, Inc.; the primary context on this page is MDGL:NASDAQ.
A2APCZ:LS
DE · EUR
Alternate listing for Madrigal Pharmaceuticals, Inc.; the primary context on this page is MDGL:NASDAQ.
0JXI:LSE
GB · USD
Alternate listing for Madrigal Pharmaceuticals, Inc.; the primary context on this page is MDGL:NASDAQ.
MDGL:BOATS
US · USD
Alternate listing for Madrigal Pharmaceuticals, Inc.; the primary context on this page is MDGL:NASDAQ.
1MDGL:MIL
IT · EUR
Alternate listing for Madrigal Pharmaceuticals, Inc.; the primary context on this page is MDGL:NASDAQ.
YDO1:FWB
DE · EUR
Alternate listing for Madrigal Pharmaceuticals, Inc.; the primary context on this page is MDGL:NASDAQ.
YDO1:BX
CH · CHF
Alternate listing for Madrigal Pharmaceuticals, Inc.; the primary context on this page is MDGL:NASDAQ.
YDO1:DUS
DE · EUR
Alternate listing for Madrigal Pharmaceuticals, Inc.; the primary context on this page is MDGL:NASDAQ.
YDO1:HAM
DE · EUR
Alternate listing for Madrigal Pharmaceuticals, Inc.; the primary context on this page is MDGL:NASDAQ.
YDO1:MUN
DE · EUR
Alternate listing for Madrigal Pharmaceuticals, Inc.; the primary context on this page is MDGL:NASDAQ.